Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.
Daughters of mothers with multiple sclerosis: their experiences of play.
Acid-sensing ion channels: trafficking and synaptic function.
Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies.
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Value of NMO-IgG determination at the time of presentation as CIS.
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States.
Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
Cannabinoids in the management of difficult to treat pain.
Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
Aquaporins: important but elusive drug targets.
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients.
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.
Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
Transplantation of Human Adipose-Derived Stem Cells Enhances Remyelination in Lysolecithin-Induced Focal Demyelination of Rat Spinal Cord.
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
Gray matter involvement in multiple sclerosis.
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
Pages
« first
‹ previous
…
168
169
170
171
172
173
174
175
176
…
next ›
last »